Printer Friendly

Carl Accettura senior director, product & supply Chain, Sunovion pharmaceuticals.

Carl Accettura is a veteran of FDA-regulated operations, with 25 years of diversified global experience in both large and small pharmaceutical firms. During the past two years, he has prepared for commercialization of a schizophrenia drug for Dainippon Sumitomo Pharma America (now Sunovion). For the previous four years, Carl prepared Kyowa Pharmaceuticals for commercialization of a novel therapy for Parkinsons Disease while running his own Rx commercialization services firm.

Mr. Accettura founded Global Pharma Consulting LLC in 2004 to provide commercialization expertise to start-up pharmaceutical and medical product firms. From 1998 to 2001, Mr. Accettura was a corporate officer and vice president of operations at Anesta Pharmaceutical, responsible for worldwide clinical & commercial manufacturing, tech transfer, validation, CMC filings and regulatory inspection and approval by MHRA and FDA.

Previously, he served as vice president, Worldwide Supply Chain Management, at Bristol-Myers Squibb ConvaTec, and as vice president, Materials Management, Hoffman-La Roche. His background also includes director-level positions at Pfizer in new product planning, strategic planning and pharmaceutical systems. He began his career as a Merck Design Engineer.

COPYRIGHT 2011 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MEET THE SPEAKERS
Publication:Contract Pharma
Date:Sep 1, 2011
Previous Article:Interview: bill hooks: UPS executive talks about Merck partnership and healthcare logistics.
Next Article:James Agalloco President, Agalloco & Associates.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters